Tesfai Sebhatu

USPTO Granted Patents = 5 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Södertälje, SE (2008 - 2011)
Sodedrtalje, SE (2011)
Sodertalje, SE (2015)
Alderley Park, GB (2015)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2008-2015

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9149539 - Crystalline naloxol-PEG conjugate (2015-10-06),

2. 9012469 - Crystalline naloxol-peg conjugate (2015-04-21),

3. 8017785 - Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine (2011-09-13),

4. 8008294 - Citrate salt of an indole derivative and its pharmaceutical use (2011-08-30),

5. 7459463 - Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt (2008-12-02),

Title: The Innovative Contributions of Tesfai Sebhatu

Introduction

Tesfai Sebhatu is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on naloxol-polyethylene glycol conjugates. With a total of 5 patents to his name, Sebhatu's inventions have the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Tesfai Sebhatu has developed crystalline naloxol-PEG conjugates. These conjugates are provided in oxalate or phosphate salt forms, including crystalline forms. His patents also detail methods for preparing these salt forms and pharmaceutical compositions that comprise them. This work represents a significant advancement in the formulation of pharmaceutical compounds.

Career Highlights

Throughout his career, Tesfai Sebhatu has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Nektar Therapeutics. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulation.

Collaborations

Tesfai has collaborated with esteemed colleagues such as Martin Hans Bohlin and Carl-Johan Aurell. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.

Conclusion

In summary, Tesfai Sebhatu's work in the field of pharmaceutical sciences showcases his innovative spirit and dedication to improving medical treatments. His contributions through patents and collaborations highlight the importance of research and development in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.